KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Net Margin (2016 - 2025)

Abbott Laboratories' Net Margin history spans 17 years, with the latest figure at 15.5% for Q4 2025.

  • For Q4 2025, Net Margin fell 6860.0% year-over-year to 15.5%; the TTM value through Dec 2025 reached 14.72%, down 1723.0%, while the annual FY2025 figure was 14.72%, 1723.0% down from the prior year.
  • Net Margin for Q4 2025 was 15.5% at Abbott Laboratories, up from 14.46% in the prior quarter.
  • Across five years, Net Margin topped out at 84.1% in Q4 2024 and bottomed at 10.24% in Q4 2022.
  • The 5-year median for Net Margin is 14.97% (2024), against an average of 18.39%.
  • The largest annual shift saw Net Margin surged 6853bps in 2024 before it tumbled -6860bps in 2025.
  • A 5-year view of Net Margin shows it stood at 17.27% in 2021, then tumbled by -41bps to 10.24% in 2022, then surged by 52bps to 15.56% in 2023, then soared by 440bps to 84.1% in 2024, then tumbled by -82bps to 15.5% in 2025.
  • Per Business Quant, the three most recent readings for ABT's Net Margin are 15.5% (Q4 2025), 14.46% (Q3 2025), and 15.97% (Q2 2025).